Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals

LXRX

#7548

Rank

$0.27 B

Marketcap

🇺🇸 United States

Country

$0.77

Share price

-4.42%

Change (1 day)

-34.60%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Lexicon Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year	P/B ratio	Change
2024-12-31	N/A	-100%
2023-12-31	4.02	30.77%
2022-12-31	3.08	-40.41%
2021-12-31	5.16	66.88%
2020-12-31	3.09	-17.83%
2019-12-31	3.77	-114.14%
2018-12-31	-26.6	-274.31%
2017-12-31	15.3	67.18%
2016-12-31	9.14	89.45%
2015-12-31	4.82	107.92%
2014-12-31	2.32	-57.26%
2013-12-31	5.43	27.86%
2012-12-31	4.25	190.06%
2011-12-31	1.46	-25.57%
2010-12-31	1.97	7.66%
2009-12-31	1.83	86.81%
2008-12-31	0.9780	-32.38%
2007-12-31	1.45	-55.97%
2006-12-31	3.29	19.62%
2005-12-31	2.75	-32.18%
2004-12-31	4.05	81.88%
2003-12-31	2.23	52.71%
2002-12-31	1.46

P/B ratio for similar companies or competitors

Company	P/B ratio	P/B ratio differencediff.	Country
Eterna Therapeutics ERNA	-3.62	-399.76%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	2.81	132.71%	🇺🇸 USA
Ultragenyx RARE	9.93	722.33%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	2.23	84.25%	🇺🇸 USA
Thermo Fisher Scientific TMO	4.01	231.79%	🇺🇸 USA
Esperion Therapeutics ESPR	-1.41	-217.08%	🇺🇸 USA
Illumina ILMN	10.2	743.48%	🇺🇸 USA
Ligand Pharmaceuticals LGND	2.86	136.50%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Lexicon Pharmaceuticals (LXRX) - P/B ratio

P/B ratio as of November 2024 : 1.21